Guggenheim Capital LLC Vericel Corp Transaction History

Guggenheim Capital LLC

  • $13.9 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$46.35 - $59.75 $275,643 - $355,333
-5,947 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$47.2 - $67.81 $28,933 - $41,567
-613 Reduced 9.34%
5,947 $312,000
Q1 2021

May 13, 2021
BUY
$30.93 - $59.48 $202,900 - $390,188
6,560 New
6,560 $364,000

Others Institutions Holding VCEL

# of Institutions
268
Shares Held
48.4M
Call Options Held
91.1K
Put Options Held
39.8K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.04B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email